07.10.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with The Hill on a recent federal court ruling concerning drug price disclosures in TV ads.
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with Pink Sheet on a recent federal court ruling concerning drug prices in TV ads.
07.09.19
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with InsideHealthPolicy on a federal court’s decision to block the Trump administration’s proposed rule to include drug prices in television ads for prescription drugs.
06.18.19
Manatt’s Jocelyn Guyer, managing director with Manatt Health, spoke with FierceHealthcare about a new report on CHIP and Medicaid, and their impact on the social and emotional well-being of children.
06.15.19
Cindy Mann, a partner with Manatt Health, spoke to POLITICO about California’s upcoming health care expansion that will extend full Medicaid benefits to undocumented young people.
06.14.19
Manatt’s Michael Kolber, a partner with Manatt Health, spoke with FierceHealthcare on the Trump administration’s expansion of health reimbursement arrangements.
06.12.19
Chiquita Brooks-LaSure, managing director at Manatt Health, served as a witness at a U.S. House of Representatives Ways and Means Committee hearing titled “Pathways to Universal Health Coverage” on June 12.
06.11.19
Manatt’s Joel Ario, a managing director with Manatt Health, spoke with Health Plan Weekly on Idaho’s proposed “Coverage Choice Waiver” for Medicaid.
06.10.19
Manatt’s Chiquita Brooks-LaSure, a managing director with Manatt Health, spoke to The Washington Post about the conflict between state governments and the Trump administration on public health coverage.
Manatt’s Jocelyn Guyer, a managing director with Manatt Health, spoke to Patient EngagementHIT about social determinants of health (SDOH) and how some healthcare experts can develop community health programming to better facilitate patient health.